Skip to main content
. 2011 May 15;13(8):1118–1126. doi: 10.1093/europace/eur102

Figure 4.

Figure 4

Hazard ratio (dronedarone 400 mg bd vs. placebo) estimates with confidence intervals according to region. (A) Primary endpoint (first cardiovascular hospitalization or death from any cause); (B) cardiovascular hospitalization. Data are for all randomized patients. aDetermined from Cox regression model. bP values are for interaction between regions and treatment based on Cox regression model.